- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
Pfizer (NYSE:PFE): Current price $26.85
Shares of the Israeli pharmaceutical firm Protalix BioTherapeutics (AMEX:PLX) have taken off, following the website Calcalist reporting that the company is in discussions to be purchased for $1 billion. Pfizer has shown interest in acquiring Protalix, but at a valuation below the amount that Protalix prefers, says the website, which adds that Protalix’s board has chosen Citigroup (NYSE:C) to manage the selling process.
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.